chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Kidneys hurt very very bad; So sick; Was in bed a week after; Extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of RENAL PAIN (Kidneys hurt very very bad), ILLNESS (So sick), BED REST (Was in bed a week after) and FATIGUE (Extreme fatigue) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022m20a) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in February 2020. Family history included Autoimmune disorder. Concurrent medical conditions included Kidney disorder (stage 2 kidney disease).    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced RENAL PAIN (Kidneys hurt very very bad), ILLNESS (So sick), BED REST (Was in bed a week after) and FATIGUE (Extreme fatigue). At the time of the report, RENAL PAIN (Kidneys hurt very very bad), ILLNESS (So sick), BED REST (Was in bed a week after) and FATIGUE (Extreme fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Heart rate: High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant products usage were not reported by the reporter. Treatment details not included.
Info has been received from a physician concerning a 3 year old white female with eczema who on 10/15/04, was vaccinated SC in the right arm with a 1st dose of varicella virus vaccine live. There was no illness at the time of vaccination. There were no concomitant medication. Subsequently, on 6/6/05 (also reported as 6/7/05)., she experienced a mild case of chickenpox. The pt was not hospitalized. The varicella lesions have subsequently resolved. Follow-up info received from a physician indicated that the child was seen on 6/8/05 with a 2 day history of papular eruptions on her trunk and extremities. The papules were excuriated and some were possibly infected vesicles. Some were noted to be crusting. The child was prescribed estrogens, conjugated (Premarin) cream prn for the adhesions. There were no relevant diagnostic test of lab data noted. There were no adverse events following prior vaccinations. She was noted to visit the physician's office 2 times. The outcome was reported as recovered. There were no adverse events following prior vaccinations of the pt or her siblings. It was noted that the child's 4 month old sibling was hospitalized with a fever and suspected varicella at the time of onset of the pt's lesions. The sibling was without lesions or serologic evidence of varicella. No additional info is expected.
Narrative: Pt seen in the ED on 10/24/18 for allergic reaction to flu shot. Was given prescriptions for Epipen (qty 1) and famotidine 20 mg PO BID for 5 days. Symptoms: ]. RASH; URTICARIA; DYSPNEA Treatment Drugs Used: 1. EPINEPHRINE Dose: Units: Freq: Route: 2. FAMOTIDINE Dose: 20 Units: Freq: BID Route:
Pt states she felt fine after receiving vaccine, but believes she had a reaction to water she was provided at the clinic. Pt states after drinking water, she developed ringing in ears, SOB, dizziness, nausea, HA. Pt states this has happened before after drinking the same brand of water (Nestle Pure Life). Symptoms resolved after rest.
Day 1-2 - mild fever, headache Day 3 - more normal Day 4-7 (present day) - stomach issues, bloating, stomach upset, gassing, nausea, diarrhea
Pt awoke with generalized weakness of peripheral muscles, progressed through the day to extreme weakness of legs. Presented to ED where she was diagnosed with Guillain Barre.
Arm felt itchy after the injection. Notably, it was not itchy at the injection site. Instead, it was itchy on the shoulder. The itching spread down to the inside of the arm, avoiding the injection site. About 10 minutes after the shot, the other arm started itching. We checked in with the pharmacist at the 15 minute mark and got the go-ahead to go home, since it was only itching.  On the drive home, about 20 minutes after the shot, the face and lips started itching. After arriving home, about 25 minutes after the shot, we noticed a small rash forming on the face. She took a benadryl and retired for the day, to be safe. The itching was still spreading about half an hour after the benadryl (60 minutes after the injection), reaching the back of her neck. However, the rash has improved since taking the benadryl and the face is less itchy. (She describes the itchy patches as moving to different parts of her body.)  It's currently only 65 minutes after the vaccine, so we're still keeping an eye on things! We wanted to report symptoms while they're fresh in mind.
NOTICED INFLAMMED CUTICLES THAT WERE SENSITIVE TO WATER WHEN I GOT UP IN MIDDLE OF NIGHT TO USE BATHROOM.  NEXT MORNING MY LEFT EYELID WAS ALSO INFLAMMED.  THIS WAS DAILY.  I STARTED HAVING ISSUES WITH MY LEFT EAR. NOTHING COULD TOUCH MY CUTICLES WITH OUT DISCOMFORT.  I GOT A RASH ON MY NECK SHOULDERS AND ARMS THAT I THOUGHT WERE STRESS HIVES.  THE RASH BECAME RED AND INFLAMMED.  WENT TO HOSPITAL CLINIC AND THEY SAID I HAD AN INFECTION BECAUSE OF THE REDNESS IN MY EAR CANAL AND ARM.  THEY PRESCRIBED AN ANTIBIOTIC AND STEROID.  I TOOK BOTH AND NOTHING IMPROVED.  BY NOW MY RANGE OF MOTION WAS DECREASING AND I WAS EXHAUSTED.  I COULD NO LONGER RAISE MY HANDS ABOVE MY HEAD AND I TOOK HOURS TO GET DRESSED.  I ALWAYS FELT LIKE I HAD DONE 30 MINUTES OF SWIMMING LAPS AND THEN TRIED TO PULL MYSELF OUT OF THE POOL FROM THE DEEP END.  I MADE AN APPOINTMENT WITH MY PCP IN JUNE
Only know 2 people that had shingles and one is a vaccinated nurse /Suspected vaccination failure; Only know 2 people that had shingles and one is a vaccinated nurse; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The patient was a vaccinated nurse. The age at vaccination was not reported. The reporter stated that he/she know the patient had shingles. The reporter stated that almost everybody had chicken pox back in his/her youth. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting. This case had been linked with US2021AMR111296, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR111296:Same reporter. Patient 1.
Swelling, redness, tenderness, around site right arm cellulitis treated with antibiotics.
Client states that her episodes of shortness of breath and dizziness occured 1 - 2 months after she received the HPV vaccine, and that she currently has episodes several times/month.
little tired; nausea; feverish; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (little tired), NAUSEA (nausea) and PYREXIA (feverish) in a 33-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037F21A and 052E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (little tired), NAUSEA (nausea) and PYREXIA (feverish). At the time of the report, FATIGUE (little tired), NAUSEA (nausea) and PYREXIA (feverish) outcome was unknown.            No concomitants and treatments are provided.  Upon internal review on 25-Oct-2021, Age units(years) populated.
Numbness on administered arm (lasted a week before going away) - no treatment taken Hot/Cold patches on administered arm (lasted a week before going away) - no treatment taken Spikes of pain in administered arm (lasted 2 weeks after shot before going away), comes back once in a while - no treatment taken Chest Pains (spikes, heaviness) - (began 10/19/2022 and is on-going) - no treatment taken yet
pt states he developed a headache, severe chills, and felt bad all over.  The arm that he was given the injections hurt for 2 days.  He called his PCP regarding his symptoms and by the time his doctor called him back he was feeling better.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 20-NOV-2014 the patient was vaccinated with ZOSTAVAX lot # J003808 and expiry date: 03-JUL-2014 (dose, route were not reported). On 20-NOV-2014 received a dose of ZOSTAVAX that was past expiration date. No adverse effects were reported. Additional information has been requested.
A non-serious spontaneous report of H1N1 Mist vaccine given to a person greater than 49-years-old was received from a registered nurse in the concerning a 54-year-old male. The patient's medical history and concomitant medications were not provided. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.
Diarrhea; severe chills; sore arm; This is a spontaneous report from a contactable other healthcare professional (patient) reported that a 59-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported) then received the second dose (lot number: EK 9231, expiration date: not reported) on 08Jan2021 13:45 both via an unspecified route of administration on the left arm at a single dose for COVID-19 immunization. Medical history included that the patient had allergies to medications, food, or other products such as Penicillin, Sulfa drug and pork. The patient was not pregnant. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included aspirin [acetylsalicylic acid] (ASPIRIN [ACETYLSALICYLIC ACID]), ascorbic acid (VIT C), ergocalciferol (VIT D) and biotin (BIOTIN). On 08Jan2021 22:45, 9 hours after vaccine the patient experienced diarrhea, severe chills and sore arm. As treatment, patient received ibuprofen (ADVIL) and fluids. The outcome of the events was recovered. Since the vaccination, the patient has not been tested for COVID-19.  Information on the lot/batch number (first dose) has been requested.
Patient arrived to receive their 3rd Pfizer COVID vaccine but was given a dose of the Moderna COVID vaccine.
Chills, Tired after both injections on both reported dates about 3 hours after administration; Chills, Tired after both injections on both reported dates about 3 hours after administration; This spontaneous case was reported by a patient and describes the occurrence of CHILLS (Chills, Tired after both injections on both reported dates about 3 hours after administration) and FATIGUE (Chills, Tired after both injections on both reported dates about 3 hours after administration) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027h21B) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: JANSSEN COVID-19 VACCINE  (Dose Number 1, Batch/Lot No. was 1802070,  Location of injection site Left arm, Vaccine Administration Time 10:45 AM) on 09-Mar-2021, JANSSEN COVID-19 VACCINE  (Dose Number 1, Batch/Lot No. was 1802070,  Location of injection site Left arm and Vaccine Administration Time 10:45 AM) on 09-Mar-2021; for Drug use for unknown indication: Iodine and sulfamethoxazole / trimethoprim. Past adverse reactions to the above products included Allergy with Iodine and sulfamethoxazole / trimethoprim; Chills with JANSSEN COVID-19 VACCINE; and Tiredness with JANSSEN COVID-19 VACCINE. Concurrent medical conditions included Pollen allergy and Dust allergy. Concomitant products included ROSUVASTATIN from 31-May-2021 to 13-Jun-2022 for an unknown indication.    On 28-Nov-2021 at 10:00 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Nov-2021, the patient experienced CHILLS (Chills, Tired after both injections on both reported dates about 3 hours after administration) and FATIGUE (Chills, Tired after both injections on both reported dates about 3 hours after administration). At the time of the report, CHILLS (Chills, Tired after both injections on both reported dates about 3 hours after administration) and FATIGUE (Chills, Tired after both injections on both reported dates about 3 hours after administration) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 13-Jun-2022 to 17-Jun-2022 for COVID-19 treatment, at an unspecified dose and frequency. Paxlovid batch no. reported GA3594. Device Date reported 23Jun2022 No treatment information was provided for the reported events.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2022: Upon internal Review on 11-Jul-2022, significant correction was performed to update Spikevax from Historical vaccine to Suspect product and previously captured suspect product PAXLOVID updated to treatment for COVID-19. Case become valid and narrative updated accordingly.
The patient came in for his shot. Once he received his shot, he sat down on the chair for observation. All of a sudden he got up and started sitting down on the floor asking to lay down. He felt dizzy, faint. He kept saying faint. He also was feeling hot. The patient drank water and was feeling better. He wasn't always answering right away. He laid there for less than 15 minutes and then was able to get up and sit on the chair for another 5-10 minutes before he left the store. He called his wife to let her know. The store manager was with the patient the whole time.
Patient told me before 2nd dose that he experienced dizziness 2 hours after the 1st dose.   He says it lasted 3 hours.   He said he ended up sitting up for a while at work.
Given vaccine @ 14:15 and taken to  observation area, no acute issues reported.  ~14:25 pt asked for water, c/o temporary LOC.  Pt laid down and feet elevated, LOC less than 7secs.  Pt very diaphoretic, cool and pale.  Pt reports feeling very hot and clammy.  EMS called and arrived within 10mins.  HR 100, SBP 115s.  Pt continued to improve over time, reporting feeling hot but less lightheaded.  Upon arrival of EMS pt HR still in the low 100s and SBP 112, no abnormal rhythm found.  EMS advised to take pt to ED for observation d/t reports of feeling dizzy and lightheaded.  Pt reports he has passed out from blood draws before and did not eat lunch prior to arriving for vaccination.
I tested Positive for a Rapid COVID on 12/31/2021. The day the symptoms started I was tested because I had some cold symptoms and the only symptoms I had was stuffy nose, cough, and some fatigue. It was very mild. I initially also tested because my children were exposed to someone who may have had COVID. I did go to the doctor for a PCR test at a clinic and took my entire family and we all tested positive whether we had symptoms or not. My PCP did offer to do Monoclonal Antibodies Infusion but at that point I was already feeling better. I mostly self-treated with Mucinex and hot tea. I did lose my sense of smell but that did come back. It was very mild. It wasn't worse than Flu. My RA is a lot worse after COVID and I am doing a follow-up 05-05-2022.
GARDASIL administered on 7/24/10 and 12/30/10. Patient describes sharp pain in deltoid at admin. site extending over an approximately 10 cm area over shoulder and upper back stating day of shot and lasting 3-4 weeks afterward.
Information has been received from a company representative who overheard a physician in a hospital talking to another physician and he said that a female who was vaccinated with a single dose of GARDASIL (lot# not provided) experienced heavy vaginal bleeding. The patient's outcome was not reported. No further information is available.
BONE ACHES; MUSCLE ACHES; HEADACHE; CHILLS; FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: 21-JUN-2021) dose was not reported, administered on 06-APR-2021 11:46 on left arm for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021 20:00, the subject experienced chills. On 06-APR-2021 20:00, the subject experienced fever. On 07-APR-2021 07:00, treatment medications included: paracetamol. On an unspecified date, the subject experienced bone aches, muscle aches, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from muscle aches, and the outcome of chills, fever, bone aches and headache was not reported. This report was non-serious.
This is in follow-up to report(s) previously submitted on 2/13/2009. Information has been received from a physician concerning a female who on was vaccinated in the deltoid with the first and second dose of GARDASIL on unspecified date and experienced nausea. On 19-JAN-2009 she was vaccinated in the deltoid with a third dose of GARDASIL. On 19-JAN-2009, the patient experienced severe vomiting, nausea and low heart rate and became weak. The patient had electrocardiogram (EKG) performed and the result was not reported. The patient sought unspecified medical attention. On the same day shortly afterwards, the patient recovered. Follow-up information was received from the physician's nurse via phone call. The patient also experienced nausea after the first and second dose of GARDASIL. Follow-up information was received. A nurse reported the patient was 16 years old. Follow-up information was received from the physician. It was reported on 19-JAN-2009 the patient was vaccinated intramuscularly in the left deltoid with a third dose of GARDASIL (lot # 661701/0691X). The patient experienced vasovagal syncope lasted 20 minutes. Subsequently the patient vomited, got nauseated and bradycardic when trying to sit up 15 minutes. Later the patient was given Gatorade resolution at 30 minutes. This is one of the several reports from the same source. No further information was available.  3/3/09 Received vaccine records & medical records from PCP. FINAL DX: vasovagal attack Records reveal patient was in good health on 9/11/06 for HPV #1.  RTC 8/27/07 for HPV #2 w/dysmenorrhea & tender lymph node on neck.  Started BCP.  RTC 5/1/08 w/depression.  Tx w/meds & referred for counseling.  RTC 9/29/08 w/strep throat.  RTC 1/19/09 for HPV #3 then fainted, vomited, nauseated, bradycardia.
HEP A, HEP B & MMR given in (L) upper arm. Arm swollen with hive - like rash from elbow to deltoid on 2/3 of arm circumference. Cold compresses - BENADRYL cream TID.
Got 2 shingles shots, still got them/suspected vaccination failure; still got them  bad; after pains; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the pain was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK receipt date: 10-JAN-2023 Reporter's comment: The case was received from the patient via  interactive digital media. The patient got the two Shingles shots and still got them bad.  The reporter stated that physician could not believe it and now patient still had the after pains every day not as bad and it was not fun (three years ago). Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. Not fun (three years ago) as it was not clear if the reporter mentioned this with referring to event or suspect hence kept in narrative only.
pt. received injection then went to sit down in chair for observation,  pt. fell to floor, stiffened body lasting about 5-10 seconds.  Pt. was rolled to her back and then pt. aroused, and was tearful.  small abrasion noted to bridge of nose,  Pt. does not recall incident.  Pt. states she has history of "passing out after shots"
Monovalent pfizer 5-11 vaccine reconstituted and labelled as bivalent. Given to patient when they should have received bivalent not monovalent.
12/2/21: 2nd COVID vaccine, right thigh IM 12/5/21: right hip pain and limp started 12/8/21: seen in clinic, pain with right hip ROM and walking, otherwise normal exam, no fever, normal pelvis and femur xrays, normal CBC and ESR, diagnosis of transient synovitis given, possibly related to recent COVID vaccine
My face and hands flushed red for about 45 minutes about 30 minutes after the injection.; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER2613) via unspecified route of administration on 18Mar2021 (at the age of 59-years-old) at 1000 (at the age of 59-years-old), as a single dose for COVID-19 immunisation. The patient medical history included myasthenia Gravis, Barret's, benign prostate hyperplasia (BHP), asthma, degenerative disc disease. The patient was allergic to actifed, biaxin, IVP dye(contrast), morphine, cologne/perfume. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had received unspecified other medications within 2 weeks of vaccination. Prior to vaccination, the patient had not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. On 18Mar2021 at 1245, the patient experienced face and hands flushed red for about 45 minutes (also reported as about 30 minutes after the injection). No therapeutic measures were taken as a result of face and hands flushed red. The clinical outcome of the event face and hands flushed red was recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.